Tumor Microenvironment Regulates Metastasis and Metastasis Genes of Mouse MMTV-PymT Mammary Cancer Cells In Vivo

Veterinary Pathology

Volumn 51, Issue 4, 2014, Pages 868-881

  Werbeck, J L ^a   Thudi, N K ^a   Martin, C K ^a   Premanandan, C ^a   Yu, L ^a   Ostrowksi, M C ^a   Rosol, T J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

bone; breast cancer; lung; mammary cancer; mammary tumor; metastasis; ovary; PyMT

Indexed keywords

ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR GENE; TUMOR MICROENVIRONMENT; VETERINARY;

ANALYSIS OF VARIANCE; ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HISTOLOGICAL TECHNIQUES; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

EID: 84907465746     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985813505116     Document Type: Article

References (67)

1. Blomme EA,Dougherty KM,Pienta KJ, et al.Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein.Prostate. 1999;39 (3): 187-197
2. Borowsky AD,Namba R,Young LJ, et al.Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior.Clin Exp Metastasis. 2005;22 (1): 47-59
3. Bronisz A,Godlewski J,Wallace JA, et al.Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.Nat Cell Biol. 2012;14 (2): 159-167
4. Cardiff RD.Validity of mouse mammary tumour models for human breast cancer: comparative pathology.Microsc Res Tech. 2001;52 (2): 224-230
5. Chambers AF,Groom AC,MacDonald IC.Dissemination and growth of cancer cells in metastatic sites.Nat Rev Cancer. 2002;2 (8): 563-572
6. Cockett MI,Murphy G,Birch ML, et al.Matrix metalloproteinases and metastatic cancer.Biochem Soc Symp. 1998;63:295-313
7. Courtneidge SA,Smith AE.Polyoma virus transforming protein associates with the product of the c-src cellular gene.Nature. 1983;303 (5916): 435-439
8. Coussens LM,Werb Z.Inflammation and cancer.Nature. 2002;420 (6917): 860-867
9. Coussens LM,Werb Z.Matrix metalloproteinases and the development of cancer.Chem Biol. 1996;3 (11): 895-904
10. DeNardo DG,Johansson M,Coussens LM.Immune cells as mediators of solid tumor metastasis.Cancer Metastasis Rev. 2008;27 (1): 11-18
11. Deng X,Tannehill-Gregg SH,Nadella MV, et al.Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases.Clin Exp Metastasis. 2007;24 (2): 107-119
12. Dey JH,Bianchi F,Voshol J, et al.Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.Cancer Res. 2010;70 (10): 4151-4162
13. Dilworth SM.Polyoma virus middle T antigen and its role in identifying cancer-related molecules.Nat Rev Cancer. 2002;2 (12): 951-956
14. Dong Z,Bonfil RD,Chinni S, et al.Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.Am J Pathol. 2005;166 (4): 1173-1186
15. Euhus DM,Hudd C,LaRegina MC, et al.Tumor measurement in the nude mouse.J Surg Oncology. 1986;31 (4): 229-234
16. Fainaru O,Adini A,Benny O, et al.Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis.FASEB J. 2008;22 (2): 522-529
17. Fidler IJ.Critical determinants of metastasis.Sem Cancer Biol. 2002;12 (2): 89-96
18. Fidler IJ.The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited.Nat Rev Cancer. 2003;3 (6): 453-458
19. Foley J,Nickerson N,Riese DJ, et al.At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone.Odontology. 2012;100 (2): 109-129
20. Fukino K,Shen L,Matsumoto S, et al.Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.Cancer Res. 2004;64 (20): 7231-7236
21. Gilmore JL,Scott JA,Bouizar Z, et al.Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.Breast Cancer Res Treat. 2008;110 (3): 493-505
22. Guise TA,Kozlow WM,Heras-Herzig A, et al.Molecular mechanisms of breast cancer metastases to bone.Clinical Breast Cancer. 2005;5 (2): S46-S53
23. Guo W,Giancotti FG.Integrin signalling during tumour progression.Nat Rev Mol Cell Biol. 2004;5 (10): 816-826
24. Guy CT,Cardiff RD,Muller WJ.Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.Mol Cell Biol. 1992;12 (3): 954-961
25. Hynes NE,Dey JH.Potential for targeting the fibroblast growth factor receptors in breast cancer.Cancer Res. 2010;70 (13): 5199-5202
26. Ichaso N,Dilworth SM.Cell transformation by the middle T-antigen of polyoma virus.Oncogene. 2001;20 (54): 7908-7916
27. Jessen KA,Liu SY,Tepper CG, et al.Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin.Breast Cancer Res. 2004;6 (3): R157-R169
28. John A,Tuszynski G.The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.Pathol Oncol Res. 2001;7 (1): 14-23
29. Joyce JA,Pollard JW.Microenvironmental regulation of metastasis.Nat Rev Cancer. 2009;9 (4): 239-252
30. Kang Y,Siegel PM,Shu W, et al.A multigenic program mediating breast cancer metastasis to bone.Cancer Cell. 2003;3 (6): 537-549
31. Kaplan RN,Riba RD,Zacharoulis S, et al.VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.Nature. 2005;438 (7069): 820-827
32. Kerbel RS,Cornil I,Theodorescu D.Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis.Cancer Metastasis Rev. 1991;10 (3): 201-215
33. Khan S,Aspe JR,Asumen MG, et al.Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential.Br J Cancer. 2009;100 (7): 1073-1086
34. Kominsky SL,Davidson NE.A “bone” fide predictor of metastasis? Predicting breast cancer metastasis to bone.J Clin Oncol. 2006;24 (15): 2227-2229
35. Kukreja SC,Rosol TJ,Wimbiscus SA, et al.Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.Endocrinology. 1990;127 (1): 305-310
36. LeRoy BE,Thudi NK,Nadella MV, et al.New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft.Prostate. 2006;66 (11): 1213-1222
37. Lorch G,Gilmore JL,Koltz PF, et al.Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice.Br J Cancer. 2007;97 (2): 183-193
38. Lorger M,Felding-Habermann B.Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.Amer J Pathol. 2010;176 (6): 2958-2971
39. Martin CK,Werbeck JL,Thudi NK, et al.Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma.Cancer Research. 2010;70 (21): 8607-8616
40. Minn AJ,Gupta GP,Siegel PM, et al.Genes that mediate breast cancer metastasis to lung.Nature. 2005;436 (7050): 518-524
41. Minn AJ,Kang Y,Serganova I, et al.Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.J Clin Invest. 2005;115 (1): 44-55
42. Mundy GR.Metastasis to bone: causes, consequences and therapeutic opportunities.Nat Rev Cancer. 2002;2 (8): 584-593
43. Park SI,Kim SJ,McCauley LK, et al.Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.Curr Protoc Pharmacol. 2010;51 ((14.15)): 1-27
44. Paszek MJ,Weaver VM.The tension mounts: mechanics meets morphogenesis and malignancy.J Mammary Gland Biol Neoplasia. 2004;9 (4): 325-342
45. Poste G,Fidler IJ.The pathogenesis of cancer metastasis.Nature. 1980;283 (5743): 139-146
46. Rosol TJ,Tannehill-Gregg SH,LeRoy BE.Animal models of bone metastasis.Cancer. 2003;97 (3): 748-757
47. Schor SL.Cytokine control of cell motility: modulation and mediation by the extracellular matrix.Prog Growth Factor Res. 1994;5 (2): 223-248
48. Sellers RS,Luchin AI,Richard V, et al.Alternative splicing of parathyroid hormone-related protein mRNA: expression and stability.J Mol Endocrinol. 2004;33 (1): 227-241
49. Simiantonaki N,Kurzik-Dumke U,Karyofylli G, et al.Loss of E-cadherin in the vicinity of necrosis in colorectal carcinomas: association with NFkappaB expression.Int J Oncol. 2007;31 (2): 269-275
50. Suarez-Cuervo C,Merrell MA,Watson L, et al.Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.Clin Exp Metastasis. 2004;21 (6): 525-533
51. Takeichi M.Cadherins in cancer: implications for invasion and metastasis.Current Opinion Cell Biol. 1993;5 (5): 806-811
52. Tannehill-Gregg SH,Levine AL,Nadella MV, et al.The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice.Clin Exp Metastasis. 2006;23 (1): 19-31
53. Tarkkonen KM,Nilsson EM,Kahkonen TE, et al.Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.PLoS One. 2012;7 (11): e49970
54. Theodorou V,Kimm MA,Boer M, et al.MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.Nat Genet. 2007;39 (6): 759-769
55. Thiolloy S,Edwards JR,Fingleton B, et al.An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.PLoS One. 2012;7 (1): e29862
56. Thudi NK,Martin CK,Murahari S, et al.Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.Prostate. 2011;71 (6): 615-625
57. Thudi NK,Shu ST,Martin CK, et al.Development of a brain metastatic canine prostate cancer cell line.Prostate. 2011;71 (12): 1251-1263
58. Tomayko MM,Reynolds CP.Determination of subcutaneous tumor size in athymic (nude) mice.Cancer Chemother Pharmacol. 1989;24 (3): 148-154
59. van Kempen LC,Ruiter DJ,van Muijen GN, et al.The tumor microenvironment: a critical determinant of neoplastic evolution.Eur J Cell Biol. 2003;82 (11): 539-548
60. Weilbaecher KN,Guise TA,McCauley LK.Cancer to bone: a fatal attraction.Nat Rev Cancer. 2011;11 (6): 411-425
61. Werb Z,Vu TH,Rinkenberger JL, et al.Matrix-degrading proteases and angiogenesis during development and tumor formation.APMIS. 1999;107 (1): 11-18
62. Whitman M,Kaplan DR,Schaffhausen B, et al.Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.Nature. 1985;315 (6016): 239-242
63. Wilson KJ,Gilmore JL,Foley J, et al.Functional selectivity of EGF family peptide growth factors: implications for cancer.Pharmacol Ther. 2009;122 (1): 1-8
64. Wilson TJ,Singh RK.Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.Biochimica Biophysica Acta. 2008;1785 (2): 85-95
65. Wiseman SM,Masoudi H,Niblock P, et al.Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.Amer J Surg. 2006;191 (5): 581-587
66. Wolfe TD,Pillai SP,Hildreth BE III, et al.Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.Clin Exp Metastasis. 2011;28 (4): 377-389
67. Yashiro M,Ikeda K,Tendo M, et al.Effect of organ-specific fibroblasts on proliferation and differentiation of breast cancer cells.Breast Cancer Res Treatment. 2005;90 (3): 307-313